Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping ...
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
The Oracle21 小时
USF adds Narcan to dorm buildings: ‘Difference between life and death’
USF “recently” added Narcan, an emergency medication that reverses an opioid overdose, to its residence halls, complying with a year-old regulation. Narcan is formally known as Naloxone. The nasal ...
verywellhealth23 天
Common Types of Nasal Sprays — and How to Use Them
Nasal sprays are available by prescription or over the counter (OTC). Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it ...
thecardiologyadvisor.com10 天
Nasal Spray Formulation of Bumetanide Under FDA Review
A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) ...
Healthline24 天
Migraine Nasal Sprays Explained
A doctor may prescribe ketorolac (Toradol), an NSAID available as a nasal spray, to help manage migraine attacks that cause severe pain. They may also recommend ketorolac as a rescue medication if ...
Newsweek22 天
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Yahoo22 天
FDA approves first nasal spray treatment for severe depression
Wed, January 22, 2025 at 1:29 PM UTC ...
AZFamily13 天
Ketamine-derived nasal spray treating Phoenix patients with severe depression
PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...
KSMU23 天
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression. Spravato is ...
scrippsnews22 天
FDA approves standalone nasal spray to treat depression
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression. The drug made by Johnson & Johnson under the brand name Spravato passed final ...
healthday22 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
High Plains Public Radio23 天
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression. Spravato is made ...